CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 6,698	$ 3,850	$ 12,331	$ 5,499
Research and Development - Related Party		250		250
General and administrative	3,635	898	5,685	1,299
Total operating expenses	10,333	4,998	18,016	7,048
Loss from operations	(10,333)	(4,998)	(18,016)	(7,048)
Interest income	228	15	255	17
Other expense	(15)	(24)	(14)	(24)
Net loss	(10,120)	(5,007)	(17,775)	(7,055)
Accretion to redemption value and cumulative dividends on preferred stock		(1,904)	(1,820)	(2,665)
Net loss attributable to common stockholders	$ (10,120)	$ (6,911)	$ (19,595)	$ (9,720)
Net loss per share attributable to common stockholders, basic	$ (0.53)	$ (2.62)	$ (1.74)	$ (3.70)
Net loss per share attributable to common stockholders, diluted	$ (0.53)	$ (2.62)	$ (1.74)	$ (3.70)
Weighted-average number of shares used in computing net loss per share, basic	19,258,066	2,633,954	11,263,804	2,627,349
Weighted-average number of shares used in computing net loss per share, diluted	19,258,066	2,633,954	11,263,804	2,627,349
Other comprehensive income (loss):
Unrealized loss on investments	$ (202)		$ (333)
Comprehensive loss	$ (10,322)	$ (5,007)	$ (18,108)	$ (7,055)